Sprint Precision Technologies
688605
Jiangsu Jingxue Insulation Technology
301010
Global Infotech
300465
Hydsoft Technology
301316
SGSG Science&Technology
300561
CN Stock MarketDetailed Quotes
002365 Qianjiang Yongan Pharmaceutical
- 9.03
- +0.25+2.85%
Not Open Dec 12 15:00 CST
2.66BMarket Cap820.91P/E (TTM)
9.03High8.75Low85.73KlotVolume8.79Open8.78Pre Close76.76MTurnover3.51%Turnover RatioLossP/E (Static)294.68MShares10.0952wk High1.33P/B2.20BFloat Cap5.3552wk Low9.66Limit Up244.00MShs Float28.37Historical High7.90Limit Down3.19%Amplitude4.11Historical Low0.10Dividend TTM8.95Avg Price32.67KlotAsk1.11%Div YieldTTM100Lot Size52.60KlotBid
Qianjiang Yongan Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -30.02%193.15M | -9.46%242.04M | 19.48%244.65M | 18.73%326.17M | 153.29%276M | 22.69%267.33M | 13.01%204.76M | 193.80%274.72M | -2.16%108.96M | -7.19%217.89M |
| Transactional financial assets | 6.84%686.98M | 1.25%655.33M | 6.73%661.28M | 13.02%630.1M | 0.39%643.02M | 49.12%647.23M | 56.49%619.55M | 22.79%557.5M | 75.27%640.53M | 56.94%434.03M |
| Notes receivable and accounts receivable | -14.00%144.66M | -8.75%173.74M | -6.02%185.44M | -6.00%171.53M | -20.83%168.2M | -41.41%190.4M | -40.55%197.32M | -43.30%182.48M | -35.54%212.45M | 7.01%324.98M |
| -Notes receivable | -95.11%729.28K | -94.08%1.49M | -65.87%4.79M | -36.50%6.06M | -64.70%14.92M | -51.55%25.16M | -76.24%14.04M | -89.63%9.54M | -57.97%42.28M | -35.25%51.92M |
| -Accounts receivable | -6.10%143.93M | 4.24%172.25M | -1.44%180.64M | -4.32%165.47M | -9.93%153.28M | -39.49%165.24M | -32.82%183.28M | -24.77%172.94M | -25.70%170.17M | 22.17%273.07M |
| Other receivables (including interest and dividends) | -5.91%5.65M | 11.85%7.76M | -27.09%6.33M | -25.40%6.05M | -21.35%6M | -40.60%6.94M | 6.96%8.69M | -30.19%8.12M | 72.65%7.63M | 6.70%11.69M |
| -Other receivable | ---- | 11.85%7.76M | ---- | ---- | ---- | -40.60%6.94M | ---- | 1.97%8.12M | ---- | 6.70%11.69M |
| Advance payment | -56.05%9.9M | -38.70%5.24M | 15.20%10.02M | 13.28%8.8M | -38.32%22.54M | -12.07%8.55M | -52.56%8.7M | -67.51%7.77M | -35.20%36.54M | -38.06%9.72M |
| Inventories | 12.37%92.12M | 4.61%85.22M | -50.49%77.61M | -53.28%69.9M | -52.22%81.98M | -51.20%81.47M | 7.55%156.76M | 2.62%149.6M | 59.78%171.57M | 72.82%166.95M |
| Receivable financing | -89.09%1.35M | -95.61%432.34K | -99.18%38.68K | ---- | 77.34%12.34M | 17.71%9.84M | -47.86%4.72M | -54.39%4.75M | -84.19%6.96M | -39.31%8.36M |
| Other current assets | 387.66%6.35M | 398.31%4.66M | -96.99%198.37K | -89.94%1.05M | 280.93%1.3M | 82.01%934.46K | -0.59%6.59M | 117.77%10.41M | -95.82%341.96K | -93.26%513.42K |
| Total current assets | -5.88%1.14B | -3.16%1.17B | -1.78%1.19B | 1.53%1.21B | 2.23%1.21B | 3.28%1.21B | 10.04%1.21B | 12.15%1.2B | 15.40%1.18B | 22.35%1.17B |
| Non Current assets | ||||||||||
| Long-term equity investment | -34.46%74.3M | -34.94%73.03M | -13.37%69.4M | -16.07%68.3M | -1.47%113.38M | 0.07%112.26M | -29.62%80.11M | -29.38%81.37M | -1.42%115.07M | -3.97%112.18M |
| Fixed assets | ---- | -9.66%910.81M | ---- | ---- | ---- | 9.91%1.01B | ---- | 2.64%970.89M | ---- | -4.05%917.35M |
| Fixed assets liquidation | ---- | -70.55%38.89K | ---- | ---- | ---- | -81.56%132.04K | ---- | 230.15%1.01M | ---- | -19.82%716.09K |
| Constru in process | ---- | 402.28%54.31M | ---- | ---- | ---- | -69.75%10.81M | ---- | 21.53%50.38M | ---- | -27.79%35.74M |
| Construction materials | ---- | -15.44%1.23M | ---- | ---- | ---- | 7.05%1.45M | ---- | -27.80%1.16M | ---- | -13.67%1.35M |
| Intangible assets | -3.40%80.41M | -3.37%81.26M | -1.82%82.11M | -2.49%82.39M | -2.48%83.24M | -2.46%84.1M | -3.95%83.64M | -3.91%84.49M | -3.77%85.35M | -2.15%86.21M |
| Goodwill | -94.10%517.42K | -94.10%517.42K | -94.10%517.42K | -94.10%517.42K | 0.00%8.77M | 0.00%8.77M | 0.00%8.77M | 0.00%8.77M | 0.00%8.77M | 0.00%8.77M |
| Deferred tax assets | 35.32%12.34M | 39.69%12.2M | 12.79%11.71M | 15.70%11.26M | -14.80%9.12M | -22.37%8.74M | 3.55%10.39M | -2.07%9.73M | -10.31%10.71M | -5.92%11.25M |
| Other non current assets | 0.04%5.2M | 7.00%6.74M | 70.06%10.04M | -17.61%17.32M | -42.05%5.2M | -46.99%6.3M | -10.51%5.9M | 135.98%21.02M | 252.61%8.97M | -1.56%11.88M |
| Total non current assets | -6.27%1.14B | -8.11%1.14B | -7.25%1.14B | -7.75%1.13B | 2.95%1.21B | 4.67%1.24B | 2.54%1.23B | 0.72%1.23B | -3.53%1.18B | -4.84%1.19B |
| Total assets | -6.08%2.28B | -5.66%2.31B | -4.54%2.32B | -3.18%2.35B | 2.59%2.43B | 3.98%2.45B | 6.13%2.43B | 6.05%2.42B | 5.11%2.36B | 6.99%2.36B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 100.00%20M | 100.00%20M | 10.29%11.03M | -74.97%10.01M | 0.00%10M | -20.00%10M | -66.67%10M | 96.34%40.01M | -50.00%10M | -79.15%12.5M |
| Notes payable and accounts payable | -23.40%117.62M | -7.64%130.34M | -32.13%133.3M | -1.30%160.65M | 71.21%153.55M | 19.68%141.12M | 88.09%196.42M | 41.65%162.77M | -0.33%89.68M | 30.49%117.91M |
| -Notes payable | ---- | ---- | --14.7M | 10,533.33%31.9M | --30.2M | --13M | ---- | --300K | ---- | ---- |
| -Accounts payable | -4.65%117.62M | 1.73%130.34M | -39.62%118.6M | -20.75%128.75M | 37.54%123.35M | 8.66%128.12M | 88.09%196.42M | 41.39%162.47M | -0.33%89.68M | 30.49%117.91M |
| Contract liabilities | -0.15%19.12M | -33.13%11.92M | -4.98%17.28M | 32.46%15.59M | -0.66%19.15M | -5.60%17.83M | -4.28%18.19M | -45.34%11.77M | -12.01%19.28M | -10.16%18.88M |
| Advance receipts | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --198.88K | ---- |
| Salaries payable | -5.37%33.66M | -20.23%29.21M | -17.68%24.73M | -12.83%37.73M | -4.04%35.57M | 17.56%36.62M | 36.12%30.04M | 1.91%43.28M | 38.09%37.07M | 38.70%31.15M |
| Taxs payable | -67.79%6.03M | -35.77%6.66M | 452.44%20.06M | 107.45%10.24M | 143.38%18.72M | -35.89%10.37M | -57.76%3.63M | -10.24%4.94M | -26.77%7.69M | 72.72%16.18M |
| Other payable (including interest and dividends) | -28.98%8.3M | -7.06%38.9M | 16.01%8.26M | 13.56%16.08M | 89.31%11.69M | 432.41%41.86M | -28.78%7.12M | 39.80%14.16M | -23.93%6.18M | -78.98%7.86M |
| -Dividend payable | ---- | -0.63%29.28M | ---- | ---- | ---- | --29.47M | ---- | ---- | ---- | ---- |
| -Other payable | ---- | -22.36%9.62M | ---- | ---- | ---- | 57.61%12.39M | ---- | 39.80%14.16M | ---- | -1.53%7.86M |
| Other current liabilities | -74.10%3.76M | -82.59%4.08M | -60.01%5.21M | -15.18%6.95M | -62.91%14.53M | -50.83%23.45M | -75.95%13.02M | -89.55%8.2M | -65.98%39.19M | -11.79%47.7M |
| Total current liabilities | -20.79%208.5M | -14.27%241.12M | -21.03%219.88M | -9.78%257.26M | 25.77%263.21M | 11.53%281.25M | 12.16%278.42M | -2.81%285.13M | -28.46%209.28M | -14.41%252.18M |
| Current liabilities | ||||||||||
| Deferred tax liabilities | -37.72%21.3M | -5.23%22.6M | -7.13%23.52M | 33.76%33.09M | 61.51%34.2M | 13.64%23.85M | 11.74%25.32M | 9.81%24.74M | -13.51%21.17M | -14.02%20.99M |
| Long term deferred income | -22.12%7.13M | -21.89%7.58M | -22.85%8.06M | -24.82%8.5M | -5.02%9.16M | -17.38%9.7M | -15.70%10.45M | -13.37%11.31M | -19.00%9.64M | -6.26%11.74M |
| Total non current liabilities | -34.43%28.43M | -10.05%30.17M | -11.73%31.58M | 15.39%41.59M | 40.69%43.36M | 2.51%33.54M | 2.04%35.77M | 1.31%36.05M | -15.31%30.82M | -11.39%32.72M |
| Total liabilities | -22.72%236.93M | -13.82%271.29M | -19.97%251.46M | -6.95%298.85M | 27.69%306.57M | 10.49%314.79M | 10.90%314.19M | -2.36%321.17M | -27.01%240.1M | -14.07%284.9M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%294.68M | 0.00%294.68M | 0.00%294.68M | 0.00%294.68M | 0.00%294.68M | 0.00%294.68M | 0.00%294.68M | 0.00%294.68M | 0.00%294.68M | 0.00%294.68M |
| Capital reserve funds | 0.23%714.43M | 0.23%714.43M | 0.02%712.92M | 0.02%712.92M | 0.01%712.78M | 0.04%712.78M | 0.06%712.78M | 0.08%712.78M | 0.52%712.68M | 1.35%712.53M |
| Surplus reserve funds | 0.00%140.73M | 0.00%140.73M | 0.00%140.73M | 0.00%140.73M | 11.08%140.73M | 11.08%140.73M | 11.08%140.73M | 11.08%140.73M | 8.88%126.7M | 8.88%126.7M |
| Retained profit | -3.00%845.26M | -5.13%835.89M | -3.23%841.37M | -4.89%812.69M | -2.07%871.43M | 4.31%881.13M | 11.65%869.45M | 17.35%854.47M | 25.42%889.83M | 25.28%844.75M |
| Less:Treasury stock | --24.18M | --13.23M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other composite income | -65.77%2.22M | -65.48%2.34M | -6.34%2.31M | 26.50%4.27M | 53.23%6.48M | 620.12%6.77M | 232.07%2.47M | 299.69%3.38M | 522.87%4.23M | 181.15%939.89K |
| Specific reserves | 25.90%21.37M | 34.37%20.35M | 52.18%20.09M | 64.21%18.62M | 67.27%16.98M | 74.28%15.15M | 74.19%13.2M | 93.93%11.34M | 91.57%10.15M | 116.59%8.69M |
| Shareholders equity without minority interests | -2.38%1.99B | -2.73%2B | -1.04%2.01B | -1.66%1.98B | 0.24%2.04B | 3.17%2.05B | 6.00%2.03B | 8.12%2.02B | 11.38%2.04B | 11.24%1.99B |
| Minority interests | -38.58%46.46M | -45.02%48.07M | -31.10%58.4M | -24.82%64.38M | -11.74%75.65M | 1.18%87.42M | -6.06%84.76M | -5.96%85.63M | -4.91%85.71M | -0.06%86.4M |
| Total shareholder equity | -3.67%2.04B | -4.46%2.04B | -2.25%2.07B | -2.60%2.05B | -0.25%2.12B | 3.08%2.14B | 5.46%2.12B | 7.46%2.1B | 10.62%2.12B | 10.72%2.07B |
| Total liabilityies and equity | -6.08%2.28B | -5.66%2.31B | -4.54%2.32B | -3.18%2.35B | 2.59%2.43B | 3.98%2.45B | 6.13%2.43B | 6.05%2.42B | 5.11%2.36B | 6.99%2.36B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
